NuGenerex Immuno-Oncology, Inc.

OTCPK:NUGX Stock Report

Market Cap: US$10.1k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

NuGenerex Immuno-Oncology Management

Management criteria checks 1/4

Key information

Joe Moscato

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure3.3yrs

Recent management updates

No updates

Recent updates

No updates

CEO

Joe Moscato (58 yo)

no data

Tenure

Mr. Joseph Moscato, also known as Joe, serves as Chief Executive Officer, President and Chairman of the Board at NuGenerex Immuno-Oncology, Inc. Mr. Moscato serves a s Chief Business Development Officer of...

Board Members

NamePositionTenureCompensationOwnership
Joseph Moscato
CEO, President & Chairmanno datano datano data
Anthony Crisci
Corporate Counselno datano datano data
Richard Purcell
Executive VP of R&D and Directorno datano datano data
Marvin Hausman
Independent Director3.4yrsno datano data
Carol Nacy
Independent Director3.3yrsno datano data
Brian McGee
Independent Directorno datano datano data
Sue Eckhardt
Independent Director3.2yrsno datano data
Craig Eagle
Member of Scientific & Clinical Advisory Board and Independent Director3.3yrsno datano data
Thomas Leonard
Independent Director3.3yrsno datano data
Jonathan Davis
Member of Scientific & Clinical Advisory Boardno datano datano data
Tamera Coyne-Beasley
Member of Scientific & Clinical Advisory Board2.6yrsno datano data
Thomas Rogers
Member of Scientific & Clinical Advisory Boardno datano datano data

3.3yrs

Average Tenure

61yo

Average Age

Experienced Board: NUGX's board of directors are considered experienced (3.3 years average tenure).